Hearing loss in children treated for multidrug-resistant tuberculosis.
about
Clinical peculiarities of tuberculosisQuality of Life, Psychological Interventions and Treatment Outcome in Tuberculosis Patients: The Indian ScenarioRecent Developments and Future Opportunities in the Treatment of Tuberculosis in ChildrenTowards early inclusion of children in tuberculosis drugs trials: a consensus statementAudiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant TuberculosisPartnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.Safety and tolerability profile of second-line anti-tuberculosis medications.Dilemma of managing asymptomatic children referred with 'culture-confirmed' drug-resistant tuberculosisAdverse effects of oral second-line antituberculosis drugs in children.The safety and tolerability of the second-line injectable antituberculosis drugs in children.New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations.Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection.Aminoglycoside-induced hearing deficits – a review of cochlear ototoxicityTreatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
P2860
Q27009986-D9B15FC0-A830-4A24-B0DA-879203449C41Q28075347-0E685F5A-0AB8-4D66-B189-B11994CA4A51Q28085210-89543218-5443-4AE9-A468-11A2443316CBQ35752740-9302D98B-4884-478B-A255-108E1C13E9D2Q37060143-68F9913D-C65E-40E1-8CC6-D1B1F3928682Q37339294-9E275BF0-DD25-49EE-9C70-CD12871B8311Q38353565-4F0BC8C9-293B-4CE4-9066-D62C907BD225Q38797948-B14C0971-5782-4C0B-AA30-26F9641AC8DFQ38837774-9BB052E4-43C7-4AB9-9809-047BFD9358B0Q38933875-067D7139-6303-49ED-8F71-339A4D4B9104Q39010772-EFCE7608-A026-45F1-BA39-434C41F2B2C9Q40065397-2C85C40C-8E61-4CB0-B750-C0131E7B8B9DQ40113341-FF1187EA-D392-437D-A86D-19412B3BB3ECQ40282057-6380A602-769C-4FA9-884A-06D43500DC6AQ46427262-E7C305E3-2CAA-4CAE-B7C6-F1728A96709AQ55407610-DC86D539-F01E-4DDE-ACE6-BAB40A8AF6AFQ56385444-E24AA5C4-04A8-41A2-98C3-18E2834ED1FDQ56889741-6A1B87DB-F2B2-4CDB-906B-1330F5DEECBB
P2860
Hearing loss in children treated for multidrug-resistant tuberculosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Hearing loss in children treated for multidrug-resistant tuberculosis.
@en
Hearing loss in children treated for multidrug-resistant tuberculosis.
@nl
type
label
Hearing loss in children treated for multidrug-resistant tuberculosis.
@en
Hearing loss in children treated for multidrug-resistant tuberculosis.
@nl
prefLabel
Hearing loss in children treated for multidrug-resistant tuberculosis.
@en
Hearing loss in children treated for multidrug-resistant tuberculosis.
@nl
P2093
P1433
P1476
Hearing loss in children treated for multidrug-resistant tuberculosis.
@en
P2093
Adam Ebrahim
Anneke C Hesseling
H Simon Schaaf
Kayleen Jacobs
Stephanie Thee
P304
P356
10.1016/J.JINF.2012.09.002
P577
2012-09-06T00:00:00Z